NNIT has been positioned as a Major Contender in Everest Group’s global Pharmaceutical R&D IT Services PEAK Matrix® assessment 2026, recognizing the company’s capabilities and market position in a pharmaceutical R&D landscape that is becoming increasingly digital, data-driven, and AI-enabled.
NNIT’s second quarter financial performance was in line with initial expectations, despite continued customer caution, particularly within the life sciences segments. Supported by targeted growth initiatives aimed at strengthening sales execution, order entry improved across all regions during the quarter, while revenue declined compared to the same period last year.
As a specialist consultancy focused on digitalization for the life sciences industry and other regulated industries, NNIT is sharpening its strategic focus in Asia. Building on its long-standing life sciences expertise in mainland China, NNIT is prioritizing customer needs that call for deep, niche expertise within the life sciences value chain.
NNIT’s first quarter financial results reflect a challenging start to the year marked by continued geopolitical turmoil and sustained customer caution, particularly within the life sciences IT consulting industry. Revenue declined compared to the same period last year, and order entry was below plan.
Claus Rydkjær joins NNIT as Chief Executive Officer. He steps into the role as the company continues executing its strategy with a strong focus on expanding its global life sciences business and strengthening its position within the Danish public sector.
NNIT launches the AI method, Lumina, to help public organisations modernize complex and ageing IT systems with lower risk and greater efficiency.
NNIT announces the launch of Alera, a validated AI platform designed to address the growing gap between rapid AI adoption and strict regulatory requirements in regulated industries such as life sciences, finance, and the public sector.
NNIT today releases its Annual Report for 2025, a year characterized by a challenging macroeconomic and geopolitical environment that weighed on customer activity and delayed several projects. Revenue and profitability declined year‑over‑year, and overall financial performance was not satisfactory.
NNIT accelerates its industry focus: With more than 30 years of experience delivering IT consultancy and digital solutions to the life science industry and the public sector, NNIT is now taking further steps in its strategic industry focus.
The Danish Agency for IT and Learning (Styrelsen for It og Læring) has, following a tender, entered into a four-year framework agreement with NNIT for the development, maintenance, and support of applications within the business area evidence databases, infrastructure components, and master data registers.
The Danish Health Data Authority has appointed NNIT to play a key role in establishing phase 1 of the program aimed at improving the use of health data - an ambitious public digitalization initiative set to unfold in Denmark over the coming years.
NNIT delivered another step‑up in profitability in the third quarter of 2025 while maintaining revenue in line with expectations despite a globally uncertain environment. Improved utilization, cost discipline, and positive order trends supported stronger margins across the business.
NNIT continued the positive momentum from late Q2 2025, driven by an uplift in customer activity and solid order
